Every geopolitical shock creates a rotation trade. Capital does not disappear during a crisis – it moves. The US-Israel-Iran conflict, now in its 19th day, has triggered one of the sharpest sector rotations in Indian equities since the Russia-Ukraine disruption of 2022. While the Nifty 50 has drawn down approximately 7 per cent since 28 February, a handful of sectors have emerged as clear relative beneficiaries.

Oil and Gas Upstream: The Commodity Windfall

The most direct beneficiaries of elevated crude prices are India’s upstream oil and gas producers. Higher crude realisations flow directly into revenues and profitability. With Brent trading around $101–103 per barrel as of 18 March – a 40 to 50 per cent premium over the pre-conflict $68–70 band – upstream producers are looking at substantially higher realisations for FY27.

The transmission mechanism is straightforward. Domestic crude production, while meeting only 10–15 per cent of India’s demand, is priced off international benchmarks. Every dollar of Brent upside translates into higher revenue per barrel for domestic producers. The risk, however, is that the government may reimpose windfall taxes if crude sustains above $100, partially clawing back the upside. Integrated energy players with diversified portfolios spanning upstream production, refining, and petrochemicals tend to trade as relative outperformers during commodity-led rotations, as strength in one segment can offset volatility in another.

Defence: Order Books and Sentiment

Geopolitical tension has both a sentiment and fundamental impact on the defence sector. The Indian government announced an emergency procurement package of approximately ₹80,000 crore in early March, signalling an acceleration of indigenous defence spending. Globally, the pattern has been unmistakable – US defence contractors like Lockheed Martin hit all-time highs as the war began, with the White House convening defence CEOs and discussing plans to quadruple weapons production.

India’s defence manufacturing ecosystem – spanning airframe manufacturers, electronics companies, missile producers, and shipbuilders – stands to benefit from a structural re-rating of global defence budgets. The current conflict validates the thesis that defence spending is a multi-year cycle, not a one-quarter event. Order book visibility for Indian defence companies stretches well into FY29–30, and the emergency procurement only adds to an already robust pipeline.

Gold and Precious Metals: The Perennial Safe Haven

Gold surged to an all-time record of $5,417 per ounce on 3 March before settling around $5,000–5,033 currently. In India, 24-karat gold is trading near ₹15,775 per gram. The drivers are structural – central bank buying (the PBoC extended gold purchases for a 15th consecutive month in January), geopolitical risk premiums at multi-decade highs, and lower real interest rates making non-yielding bullion more attractive relative to fixed income.

The precious metals ecosystem in India extends beyond physical gold. Gold ETFs, sovereign gold bonds, and jewellery companies with strong brand franchises all participate in the asset-class rotation. However, at current elevated prices, physical retail jewellery demand has softened – Indian consumers are delaying discretionary purchases, while investment-grade buying through ETFs and SGBs remains robust.

Pharmaceuticals: The Classic Defensive

The pharma sector acts as a textbook defensive play in risk-off environments. Indian pharmaceutical companies have limited direct crude exposure, derive significant revenues from exports (benefiting from rupee weakness), and cater to non-discretionary healthcare demand. During periods of elevated volatility and inflation risk, institutional portfolios tend to rotate towards pharma as a margin-of-safety allocation.

Additionally, India’s role as the ‘pharmacy of the world’ gains strategic significance during geopolitical disruptions. Supply chain diversification away from China, accelerated by the post-COVID rethink, continues to channel generic manufacturing mandates towards Indian companies. The conflict, while not directly positive for pharma, provides a relative haven that is likely to see sustained institutional interest.

Renewables: The Structural Beneficiary

Every oil shock strengthens the policy conversation around energy independence and renewables. As crude price volatility exposes the fragility of import-dependent economies like India, the strategic case for solar, wind, and green hydrogen intensifies. This is not an immediate trading catalyst but a medium-term structural tailwind.

India’s renewable energy capacity addition targets, already ambitious under the National Green Hydrogen Mission and the 500 GW renewable capacity goal by 2030, gain additional political urgency when households face LPG shortages and rising fuel costs. The current conflict has forced IIT Bombay to alter its hostel menu due to LPG unavailability and shut gas-based crematoriums in Pune – these ground-level impacts create public pressure that accelerates policy action.

Domestic Consumption: The Insulated Pocket

Companies with predominantly domestic revenue streams, minimal import dependence, and pricing power over their end consumers represent another pocket of relative resilience. Utilities, hospitals, select FMCG names with strong distribution moats, and digital economy platforms tend to be less sensitive to crude and currency shocks. The key filter is operating leverage – companies whose cost structures are predominantly rupee-denominated and whose revenues are driven by domestic consumption patterns rather than global commodity cycles.

The rotation into these sectors is already visible in market flows. While FII selling has been concentrated in IT, financials, and crude-sensitive industrials, domestic institutional investors have been accumulating defensive and consumption-oriented names. This divergence is a hallmark of geopolitical risk-off phases and tends to persist until the catalyst (in this case, the war and its economic consequences) reaches a resolution.

Disclaimer:
This blog is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any financial instrument. Views expressed are based on publicly available information and market understanding at the time of writing and are subject to change. Readers should consult their financial advisor before making any investment decisions. Investments in markets are subject to risk.